F
Clovis Oncology, Inc. CLVSQ
OTC PK
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2022 06/30/2022 03/31/2022 12/31/2021 09/30/2021
Revenue 30.66M 32.14M 34.25M 35.97M 37.92M
Total Other Revenue -- -- -- -- --
Total Revenue 30.66M 32.14M 34.25M 35.97M 37.92M
Cost of Revenue 7.27M 7.87M 8.07M 8.39M 8.51M
Gross Profit 23.40M 24.27M 26.18M 27.58M 29.41M
SG&A Expenses 30.38M 32.59M 29.21M 33.35M 32.20M
Depreciation & Amortization 1.34M 1.34M 1.34M 1.34M 1.34M
Other Operating Expenses 5.12M 13.29M 3.73M 3.49M 3.84M
Total Operating Expenses 74.90M 91.52M 84.61M 88.38M 92.11M
Operating Income -44.24M -59.38M -50.36M -52.41M -54.19M
Income Before Tax -55.98M -71.37M -60.29M -64.67M -67.40M
Income Tax Expenses 35.00K -41.00K -120.00K -279.00K 13.00K
Earnings from Continuing Operations -56.01M -71.33M -60.17M -64.39M -67.41M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -56.01M -71.33M -60.17M -64.39M -67.41M
EBIT -44.24M -59.38M -50.36M -52.41M -54.19M
EBITDA -42.35M -57.48M -48.44M -50.41M -52.17M
EPS Basic -0.39 -0.50 -0.44 -0.50 -0.56
Normalized Basic EPS -0.24 -0.31 -0.27 -0.30 -0.33
EPS Diluted -0.39 -0.50 -0.44 -0.50 -0.56
Normalized Diluted EPS -0.24 -0.31 -0.27 -0.30 -0.33
Average Basic Shares Outstanding 144.63M 144.04M 138.21M 128.47M 121.22M
Average Diluted Shares Outstanding 144.63M 144.04M 138.21M 128.47M 121.22M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings